| Nov 7 |
Gilead Sciences, Inc. (GILD) Q3 2024 Earnings Call Transcript
|
| Nov 6 |
Gilead (GILD) Reports Q3 Earnings: What Key Metrics Have to Say
|
| Nov 6 |
Gilead Sciences in charts: Revenue from major products rises Y/Y in Q3
|
| Nov 6 |
Gilead rises as it raises 2024 sales, non-GAAP EPS outlook
|
| Nov 6 |
Gilead Sciences (GILD) Q3 Earnings and Revenues Surpass Estimates
|
| Nov 6 |
Gilead Sciences Rides Covid Treatment To Another Beat And Raise
|
| Nov 6 |
Gilead 3rd-quarter results beat Wall Street estimates, raises outlook
|
| Nov 6 |
Gilead: Q3 Earnings Snapshot
|
| Nov 6 |
Gilead Sciences Non-GAAP EPS of $2.02 beats by $0.47, revenue of $7.55B beats by $550M
|
| Nov 6 |
Gilead Sciences Announces Third Quarter 2024 Financial Results
|
